Search

This month’s Friday Five covers cases relating to interpretation of regulatory deadlines, the enforceability of discretionary clauses, circuit courts going both ways on appeals from summary judgment rulings in favor of plans, and a benefits award for a former professional football player where the...

NEXT STEPS FOR INVESTORS AND DETAILS ON SALTAIRE (URBAN) & TWIN LAKES (RURAL) PROJECTS Rohit Kapuria, a Partner in the Firm's EB-5 Practice, to speak at an EB5 Affiliate Network Webinar. The webinar will cove the current state of the EB-5 Regional Center Program following the recent court ruling...

Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...

Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

Saul Ewing securities attorneys Justin B. Ettelson, Michael A. Gold, Mark I. Gruhin, Andrew F. Barris and Jourdan S. Garvey have co-edited the 2021 edition of SEC Reporting Rules books.* For those responsible for filing reports with the SEC for public companies, the 2021 SEC Reporting Rules books...